Pedro Borrego

593 total citations
32 papers, 408 citations indexed

About

Pedro Borrego is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Pedro Borrego has authored 32 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 18 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Pedro Borrego's work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (9 papers). Pedro Borrego is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (9 papers). Pedro Borrego collaborates with scholars based in Portugal, United States and Spain. Pedro Borrego's co-authors include Nuno Taveira, Helena Barroso, Inês Bártolo, Alexandre Quintas, Cheila Rocha, Francisco Antunes, Manuela Doroana, Fernando Maltêz, Perpétua Gómes and Carlos Família and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Pedro Borrego

29 papers receiving 406 citations

Peers

Countries citing papers authored by Pedro Borrego

Since Specialization

Citations

This map shows the geographic impact of Pedro Borrego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Borrego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Borrego more than expected).

Fields of papers citing papers by Pedro Borrego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Borrego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Borrego. The network helps show where Pedro Borrego may publish in the future.

Co-authorship network of co-authors of Pedro Borrego

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Borrego. A scholar is included among the top collaborators of Pedro Borrego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Borrego. Pedro Borrego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Social Work and Human Rights: Uncrossed Paths Between Exposure, Engagement, Lens, and Methods in Professional Practice 2025 ·Social Sciences ·(unknown), (unknown), Pedro Borrego	0
2	Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Pedro Borrego, Álvaro Lassaletta	0
3	A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies 2020 ·Vaccines ·(unknown), Joana Duarte, Pedro Borrego, (unknown), Inês Bártolo, Francisco Martı́n, Inês Figueiredo, S. C. P. Almeida, Luís Graça, Jorge M. B. Vítor, Frederico Aires‐da‐Silva, (unknown), (unknown), Nuno Taveira	4
4	Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain 2020 ·Scientific Reports ·Claudia Palladino, Ifeanyi Jude Ezeonwumelu, (unknown), Pedro Borrego, (unknown), (unknown), Salvador Resino, Nuno Taveira, Verónica Briz	0
5	Diagnosis of sleep apnea in patients with stable chronic heart failure using a portable sleep test diagnostic device 2018 ·Sleep And Breathing ·Inês Araújo, Filipa Marquês, (unknown), (unknown), Sara Marques, Rita Ferreira, (unknown), (unknown), Pedro Borrego, Cândida Fonseca	11
6	In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2 2018 ·Antiviral Research ·Inês Bártolo, Pedro Borrego, Perpétua Gómes, (unknown), (unknown), (unknown), Nuno Taveira	2
7	Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells 2017 ·AIDS ·Cheila Rocha, Joana Duarte, Pedro Borrego, (unknown), (unknown), Rita Tendeiro, Emília Valadas, Ana E. Sousa, Nuno Taveira	3
8	Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola 2016 ·AIDS Research and Human Retroviruses ·Inês Bártolo, (unknown), Pedro Borrego, Thomas Leitner, Nuno Taveira	9
9	Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors 2016 ·AIDS ·Catarina Cunha-Santos, Tiago N. Figueira, Pedro Borrego, (unknown), Cheila Rocha, (unknown), (unknown), (unknown), José Miguel Azevedo‐Pereira, C.M.G.A. Fontes, Nuno Taveira, Frederico Aires‐da‐Silva, Miguel A. R. B. Castanho, Ana Salomé Veiga, João Gonçalves	9
10	A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support 2016 ·Retrovirology ·Matthias Döring, Pedro Borrego, Joachim Büch, (unknown), (unknown), Ricardo Camacho, Josef Eberle, Rolf Kaiser, Thomas Lengauer, Nuno Taveira, Nico Pfeifer	9
11	Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides 2015 ·Nanoscale ·Verónica Briz, Daniel Sepúlveda‐Crespo, (unknown), Pedro Borrego, Berta Rodés, F. Javier de la Mata, Rafael Gómez, Nuno Taveira, María Ángeles Muñoz‐Fernández	30
12	An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity 2013 ·AIDS ·Pedro Borrego, (unknown), (unknown), Patricia Marques Pereira, Alexandre Quintas, Helena Barroso, Nuno Taveira	27
13	Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response 2013 ·Retrovirology ·Cheila Rocha, (unknown), Pedro Borrego, (unknown), Inês Bártolo, (unknown), Patrícia Cavaco‐Silva, Perpétua Gómes, Carlos Família, Alexandre Quintas, (unknown), Thomas Leitner, Helena Barroso, Nuno Taveira	9
14	HIV-2 susceptibility to entry inhibitors. 2013 ·PubMed ·Pedro Borrego, Nuno Taveira	5
15	Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism 2012 ·AIDS ·(unknown), Pedro Borrego, Charlotta Nilsson, Carlos Família, Helena Barroso, Fernando Maltêz, Manuela Doroana, Francisco Antunes, Alexandre Quintas, Nuno Taveira	13
16	Genetic Diversity and Drug Resistance Profiles in HIV Type 1- and HIV Type 2-Infected Patients from Cape Verde Islands 2011 ·AIDS Research and Human Retroviruses ·(unknown), Inês Bártolo, Pedro Borrego, Cheila Rocha, Emília Valadas, Jorge Barreto, (unknown), Francisco Antunes, Nuno Taveira	9
17	Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System 2011 ·Value in Health ·J Félix, Valeska Andreozzi, Marta Soares, Pedro Borrego, Helena Gervásio, (unknown), Luís Costa, (unknown), (unknown), (unknown), Francisco Pina, Cristina Albuquerque, Abel Santos, José Luís Passos‐Coelho	30
18	Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection 2011 ·PLoS ONE ·Helena Barroso, Pedro Borrego, Inês Bártolo, (unknown), Carlos Família, Alexandre Quintas, Nuno Taveira	27
19	Origin and Epidemiological History of HIV-1 CRF14_BG 2011 ·PLoS ONE ·Inês Bártolo, Ana Abecasis, Pedro Borrego, Helena Barroso, Francine McCutchan, Perpétua Gómes, Ricardo Camacho, Nuno Taveira	21
20	The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients 2008 ·Retrovirology ·Pedro Borrego, (unknown), Cheila Rocha, Manuela Doroana, Francisco Antunes, Fernando Maltêz, Perpétua Gómes, Carlos Novo, Helena Barroso, Nuno Taveira	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact